Form D · Private Equity Fund
Cobalt Medical Opportunity Fund III, LP
Dallas, TX · CIK 0001623930
Offering snapshot reported Nov 5, 2014 · SEC filing
- Reported sold
- $1.3M Offering amount: $10M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Oct 27, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2014 | Initial | $1,300,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-227704
Source: Form D, filed Nov 5, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thad Bydlon | Director, Executive |
| Erik De Vries | Director, Executive |
| Matt Moore | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
14911 Quorum Drive, Suite 380
Dallas, TX, 75254
Dallas, TX, 75254